Third Harmonic Bio Inc (NASDAQ: THRD) kicked off on Tuesday, down -5.15% from the previous trading day, before settling in for the closing price of $11.65. Over the past 52 weeks, THRD has traded in a range of $4.06-$12.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -68.92%. With a float of $16.24 million, this company’s outstanding shares have now reached $40.10 million.
In an organization with 30 employees, it is important to assess its efficiency.
Third Harmonic Bio Inc (THRD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Third Harmonic Bio Inc is 60.11%, while institutional ownership is 43.17%. The most recent insider transaction that took place on Apr 11 ’24, was worth 165,214. In this transaction CEO of this company sold 13,558 shares at a rate of $12.19, taking the stock ownership to the 1,218,836 shares. Before that another transaction happened on Apr 04 ’24, when Company’s CHIEF ADMINISTRATIVE OFFICER sold 1,107 for $10.00, making the entire transaction worth $11,070. This insider now owns 0 shares in total.
Third Harmonic Bio Inc (THRD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -68.92% per share during the next fiscal year.
Third Harmonic Bio Inc (NASDAQ: THRD) Trading Performance Indicators
Take a look at Third Harmonic Bio Inc’s (THRD) current performance indicators. Last quarter, stock had a quick ratio of 50.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Third Harmonic Bio Inc (THRD)
Let’s dig in a bit further. During the last 5-days, its volume was 0.3 million. That was better than the volume of 0.14 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.78%. Additionally, its Average True Range was 0.80.
During the past 100 days, Third Harmonic Bio Inc’s (THRD) raw stochastic average was set at 71.28%, which indicates a significant increase from 53.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.43% in the past 14 days, which was lower than the 61.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.08, while its 200-day Moving Average is $8.21. However, in the short run, Third Harmonic Bio Inc’s stock first resistance to watch stands at $12.00. Second resistance stands at $12.94. The third major resistance level sits at $13.75. If the price goes on to break the first support level at $10.25, it is likely to go to the next support level at $9.44. Assuming the price breaks the second support level, the third support level stands at $8.50.
Third Harmonic Bio Inc (NASDAQ: THRD) Key Stats
The company with the Market Capitalisation of 449.85 million has total of 40,757K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -30,820 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,840 K.
